Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • MDI Biological Laboratory Scientist Receives Scientific Innovation Award

    Nov 30, 2018, 11:17 AM by Michael Croft
    BAR HARBOR, ME, UNITED STATES - Nov 30, 2018 - Vicki P. Losick, Ph.D., has been named the inaugural recipient of an award from the William Procter Scientific Innovation Fund
    Full story
  • Greenphire Named to Deloitte's 2018 Technology Fast 500™ for Fifth Consecutive Year

    Nov 30, 2018, 09:45 AM by Michael Croft
    KING OF PRUSSIA, PA, UNITED STATES - Nov 27, 2018 - Greenphire, the global leader in financial technology for clinical trials, announced today that it has been ranked as 391 on Deloitte's 2018 Technology Fast 500™
    Full story
  • CD Genomics Announces Highly Accurate and Sensitive MicroRNA Expression Profiling Microarray for Conducting a Genome-wide Analysis

    Nov 30, 2018, 01:59 AM by Michael Croft
    SHIRLEY, NY - Nov 30, 2018 - CD Genomics, an expert in transcriptomics and next generation sequencing company, announces the launch of its microRNA expression profiling  microarray services, which are based on some of the most powerful platforms in this field with unrivaled accuracy and sensitivity
    Full story
  • Facing Backlash, Chinese Scientist Defends Gene-Editing Research On Babies

    Nov 28, 2018, 12:30 PM by Michael Croft
    NPR.org | He Jiankui, who shocked the world by asserting he had genetically edited twin girls, faced growing criticism from other researchers as he spoke at a scientific conference in Hong Kong.
    Full story
  • UberCloud, The Wellcome Sanger Institute, Panasas, And More: News From November 2018

    Nov 28, 2018, 11:35 AM by Michael Croft

    Bio-IT World | November featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including UberCloud, the Wellcome Sanger Institute, Panasas, and more.

    Full story
  • Certara Launches Trial Simulator 2.3 to Improve Clinical Trial Success

    Nov 28, 2018, 11:14 AM by Michael Croft
    PRINCETON, NJ - Nov 28, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced the launch of version 2
    Full story
  • CanDIG to Power Canadian National Genomics Data Service, CHORD

    Nov 27, 2018, 14:45 PM by Michael Croft
    TORONTO, ON, CANADA - Nov 27, 2018 - Data volumes everywhere are growing rapidly. In genomics — the study of the entirety of genetic information of individuals and populations— new sequencing technologies and techniques are turning this flood into a torrent, and all of that new data holds the promise of delivering new insights into biology, health, and disease
    Full story
  • FDA Selects ArisGlobal Next-Generation Safety Platform to Implement New Integrated Safety Platform

    Nov 27, 2018, 09:09 AM by Michael Croft
    MIAMI, FL, UNITED STATES - Nov 27, 2018 - The U.S. Food and Drug Administration  (FDA) has selected Booz Allen Hamilton to support development, modernization, and enhancement of the FDA Adverse Event Reporting System (FAERS)
    Full story
  • Check4Cancer launches innovative prostate cancer diagnosis pathway with AXA PPP healthcare

    Nov 27, 2018, 05:06 AM by Michael Croft
    CAMBRIDGE, UK - Nov 27, 2018 - Prostate cancer is the most common cancer in men, with 1 in 8 diagnosed at some point in their lives
    Full story
  • The Pistoia Alliance Announces Major Milestone in Unified Data Model Project to Promote Life Sciences Collaboration

    Nov 27, 2018, 04:38 AM by Michael Croft
    BOSTON, MA - Nov 27, 2018 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today announced the latest release of its Unified Data Model (UDM) file format, v5
    Full story
  • Everest Group Names HCL Technologies a Leader for Life Sciences Digital Services in North America

    Nov 26, 2018, 12:52 PM by Michael Croft
    NOIDA, INDIA - Nov 26, 2018 - HCL Technologies (HCL), a leading global technology company, today announced that it has been recognized as a Leader in Everest Group’s Life Sciences Digital Services North America PEAK Matrix™
    Full story
  • LGC acquires Seracare Life Sciences, strengthening its position in clinical quality control tools

    Nov 26, 2018, 11:34 AM by Michael Croft
    TEDDINGTON, UNITED KINGDOM - Nov 26, 2018 - Today, LGC announced the acquisition of SeraCare Life Sciences, Inc., a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories
    Full story
  • Claim Of CRISPR'ed Baby Girls Stuns Genome Editing Summit

    Nov 26, 2018, 08:14 AM by Michael Croft
    STAT | A researcher's claim that he used genome editing to alter DNA of human embryos, resulting in the birth a few weeks ago of twin girls, stunned scientists.
    Full story
  • Creative Biolabs Developed Anti-membrane Protein Antibody Using Phage Display Technology

    Nov 24, 2018, 01:59 AM by Michael Croft
    SHIRLEY, NY - Nov 24, 2018 - Shirley, NY, Nov 24th, 2018, Creative Biolabs, as one of excellent suppliers and manufacturers in antibody production field, announced that the anti-membrane protein antibody1 has been developed successfully by using the phage display technology, which plays very crucial role in a majority of life science researches
    Full story
  • TARGET PharmaSolutions® to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead Sciences

    Nov 21, 2018, 13:26 PM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Nov 20, 2018 - TARGET PharmaSolutions, Inc., a company focused on real world evidence, is pleased to announce that it has entered into a strategic partnership with Gilead Sciences for TARGET-NASH and TARGET-HBV
    Full story
  • Single-Cell Sequencing Is Opening Up New Avenues For Potential Treatments

    Nov 21, 2018, 07:50 AM by Michael Croft
    STAT | By quickly analyzing thousands - even millions - of cells, it's now possible to visualize the specific cellular culprits for any given disease.
    Full story
  • Creative Enzymes Rolls Out 5% Discount for Thanksgiving Sale

    Nov 21, 2018, 05:19 AM by Michael Croft
    NEW YORK CITY, NY, UNITED STATES - Nov 21, 2018 - Creative Enzymes has launched the Thanksgiving Sale with 5% discount for all products and services. And this discount is available from Nov
    Full story
  • Researchers Assemble Pan-Genome From 910 Humans Of African Descent Using Deep Sequencing

    Nov 20, 2018, 15:20 PM by Michael Croft

    Bio-IT World | Researchers from Johns Hopkins University and other institutions recently conducted a study that used a deeply sequenced dataset of over 900 individuals of African descent to construct a set of DNA sequences that is missing from the current reference human genome.

    Full story
  • University of Birmingham to deploy largest IBM POWER9 AI cluster in the UK

    Nov 20, 2018, 07:30 AM by Michael Croft
    SHEFFIELD, UNITED KINGDOM - Nov 20, 2018 - Researchers at the University of Birmingham are set to benefit from the largest IBM® POWER9™ Artificial Intelligence (AI) cluster in the UK, delivering unprecedented performance for AI workloads
    Full story
  • Data Science Foundation: Findable, Accessible Data

    Nov 19, 2018, 15:45 PM by Michael Croft

    Bio-IT World | Adam Margolin, the new Director of the Icahn Institute for Data Science & Genomic Technology, says the most foundational aspect of data science is not number crunching, but actually finding to data. If we could integrate data coming out of all of our molecular profiling studies, for instance, Margolin says, it would revolutionize our ability to understand patients. 

    Full story
  • «
  • 251
  • 252 (current)
  • 253
  • 254
  • 255
  • 256
  • 257
  • 258
  • 259
  • 260
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy